BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4327585)

  • 1. Susceptibility of differentiating muscle cells of the fetal mouse in culture to coxsackievirus A13.
    Goldberg RJ; Crowell RL
    J Virol; 1971 Jun; 7(6):759-69. PubMed ID: 4327585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of susceptibility to coxsackievirus A2 by the rat L8 cell line during myogenic differentiation.
    Schultz M; Crowell RL
    J Gen Virol; 1980 Jan; 46(1):39-49. PubMed ID: 7351536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The permissiveness of differentiating mouse muscle-cell cultures to infection by group A coxsackievirus types 1 and 5.
    Landau BJ; Crowell RL; Boclair CW; Zajac BA
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):753-8. PubMed ID: 4566751
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the susceptibility of primary fetal mouse cells in culture to coxsackievirus A13.
    Goldberg RJ; Gravell M; Crowell RL
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):743-8. PubMed ID: 4311211
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrier cultures of human fetal diploid cells infected with coxsackievirus type B2.
    Maverakis NH; Schmidt NJ; Riggs JL; Lennette EH
    Arch Gesamte Virusforsch; 1973; 43(4):289-96. PubMed ID: 4207284
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of myoblast fusion after one round of DNA synthesis in 5-bromodeoxyuridine.
    Bischoff R; Holtzer H
    J Cell Biol; 1970 Jan; 44(1):134-50. PubMed ID: 4242927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the interaction between coxsackievirus A9 and HeLa cells. II. Mode of growth of coxsackievirus A9 in HeLa cell cultures and the effect of sulfated polysaccharide on plaque formation.
    Matsumoto M; Nakano M; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):77-90. PubMed ID: 184326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytochemical differentiation of nucleic acids and localization of a virus antigen in cells of tissue cultures infected with Coxsackie viruses].
    Maksimovich NO; Turchin IS; Girin VM; Buzhievs'ka TI; Vasina OG
    Mikrobiol Zh; 1967; 29(3):228-35. PubMed ID: 4979723
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological studies of the embryonic muscle cell surface. Antiserum to the prefusion myoblast.
    Friedlander M; Fischman DA
    J Cell Biol; 1979 Apr; 81(1):193-214. PubMed ID: 90049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the interaction between coxsackievirus A9 and HeLa cells. I. Plaque-forming ability of coxsackievirus A9 in HeLa cell cultures.
    Matsumoto M; Nakano M; Nishikawa F; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):67-76. PubMed ID: 184325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonproductive infection of guinea pig cells with human cytomegalovirus.
    Fioretti A; Furukawa T; Santoli D; Plotkin SA
    J Virol; 1973 Jun; 11(6):998-1003. PubMed ID: 4351465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of human lymphoblasts (RPMI 7466) to viral infections in vitro.
    Wallace RE
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):702-10. PubMed ID: 4304349
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration of capsid proteins of coxsackievirus A13 by low ionic concentrations.
    Cords CE; James CG; McLaren LC
    J Virol; 1975 Feb; 15(2):244-52. PubMed ID: 163352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence staining of group B coxsackieviruses.
    French ML; Schmidt NJ; Emmons RW; Lennette EH
    Appl Microbiol; 1972 Jan; 23(1):54-61. PubMed ID: 4621797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
    Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
    Vopr Virusol; 1988; 33(4):469-74. PubMed ID: 2848368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eclipse of coxsackievirus infectivity: the restrictive event for a non-fusing myogenic cell line.
    Schultz M; Crowell RL
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1725-34. PubMed ID: 6308134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of coxsackievirus A by Enterovirus genus-specific immune and molecular markers in experimentally infected suckling mice.
    Nsaibia S; Ben Othman S; Trabelsi A; Bourlet T; Aouni M; Pozzetto B
    Pathol Biol (Paris); 2005 Jul; 53(6):318-23. PubMed ID: 16004942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enterovirus cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole.
    Bablanian R; Eggers HJ; Tamm I
    J Bacteriol; 1966 Mar; 91(3):1289-94. PubMed ID: 4956333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and cytopathic effects of Nelson Bay virus.
    Gard G; Compans RW
    J Virol; 1970 Jul; 6(1):100-6. PubMed ID: 4097231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticellular serum on the attachment of enteroviruses to HeLa cells.
    Axler DA; Crowell RL
    J Virol; 1968 Aug; 2(8):813-21. PubMed ID: 4302746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.